Patents by Inventor Nicholas Toriello

Nicholas Toriello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190161786
    Abstract: Provided herein are systems and components thereof for improving protease activity. The systems make use of an emulsion for in vitro compartmentalization of a library of synthetic compounds, each compound having a gene linked to a protease substrate and selectable marker. Expressed enzymes with greater protease activity will preferentially hydrolyze the protease substrate, whereas enzymes with less protease activity will leave the substrate intact. Removal of the non-hydrolyzed compounds provides an enriched gene library encoding for more active protease variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2017
    Publication date: May 30, 2019
    Applicant: NOVOZYMES A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich
  • Publication number: 20180355404
    Abstract: Provided herein are methods and means for enhancing lipase activity. The system makes use of an emulsion for in vitro compartmentalization of a library of synthetic compounds which have a polynucleotide linked to a lipase substrate (e.g., a triglyceride). Expressed polypeptides having greater lipase activity will preferentially hydrolyze the substrate from the linked polynucleotide. Genes encoding polypeptides having less lipase activity will remain linked to the substrate and may be removed to enrich the library for more active variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2016
    Publication date: December 13, 2018
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Allan Svendsen, Jesper Brask, Anne Olsen, Kathleen Hirano, Amy Twite
  • Patent number: 9969970
    Abstract: The present invention provides conjugates of DNA and cells by linking the DNA to a native functional group on the cell surface. The cells can be without cell walls or can have cell walls. The modified cells can be linked to a substrate surface and used in assay or bioreactors.
    Type: Grant
    Filed: March 1, 2016
    Date of Patent: May 15, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Shih-Chia Hsiao, Matthew B. Francis, Carolyn Bertozzi, Richard Mathies, Ravi Chandra, Erik Douglas, Amy Twite, Nicholas Toriello, Hiroaki Onoe
  • Publication number: 20180073017
    Abstract: Provided herein are methods and means for enhancing enzymatic activity. The system makes use of an emulsion for in vitro compartmentalization of a library of synthetic compounds which have a gene and a marked enzymatic substrate both directly linked to a solid phase. Expressed enzymes with greater activity will preferentially release the selectable marker from the solid phase, whereas enzymes with less activity will leave the markers intact. Removal of the marked compounds provides an enriched gene library encoding for more active variants. Also described are synthetic compounds and emulsions which can be used in the methods.
    Type: Application
    Filed: April 7, 2016
    Publication date: March 15, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Allan Svendsen
  • Publication number: 20170369860
    Abstract: The present invention relates to endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, expression vectors, and recombinant host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 6, 2016
    Publication date: December 28, 2017
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Charles Emrich, Nicholas Toriello, Hanshu Ding, David Osborn, Aubrey Jones
  • Publication number: 20160319238
    Abstract: The present invention provides conjugates of DNA and cells by linking the DNA to a native functional group on the cell surface. The cells can be without cell walls or can have cell walls. The modified cells can be linked to a substrate surface and used in assay or bioreactors.
    Type: Application
    Filed: March 1, 2016
    Publication date: November 3, 2016
    Inventors: Shih-Chia Hsiao, Matthew B. Francis, Carolyn Bertozzi, Richard Mathies, Ravi Chandra, Erik Douglas, Amy Twite, Nicholas Toriello, Hiroaki Onoe
  • Patent number: 9327036
    Abstract: The present invention provides conjugates of DNA and cells by linking the DNA to a native functional group on the cell surface. The cells can be without cell walls or can have cell walls. The modified cells can be linked to a substrate surface and used in assay or bioreactors.
    Type: Grant
    Filed: April 8, 2010
    Date of Patent: May 3, 2016
    Assignee: The Regents of the University of California
    Inventors: Shih-Chia Hsiao, Matthew B. Francis, Carolyn Bertozzi, Richard Mathies, Ravi Chandra, Erik Douglas, Amy Twite, Nicholas Toriello, Hiroaki Onoe
  • Publication number: 20150218553
    Abstract: The present invention provides methods based on screening expressed polynucleotide libraries for soluble proteins.
    Type: Application
    Filed: September 20, 2013
    Publication date: August 6, 2015
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich
  • Patent number: 9080162
    Abstract: This invention provides novel variant cellulolytic enzymes having improved activity and/or stability. In certain embodiments the variant cellulotyic enzymes comprise a glycoside hydrolase with or comprising a substitution at one or more positions corresponding to one or more of residues F64, A226, and/or E246 in Thermobifida fusca Cel9A enzyme. In certain embodiments the glycoside hydrolase is a variant of a family 9 glycoside hydrolase. In certain embodiments the glycoside hydrolase is a variant of a theme B family 9 glycoside hydrolase.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: July 14, 2015
    Assignee: Novozymes, A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Richard N. Cohen, Nitzan Koppel
  • Publication number: 20140113335
    Abstract: This invention provides novel variant cellulolytic enzymes having improved activity and/or stability. In certain embodiments the variant cellulotyic enzymes comprise a glycoside hydrolase with or comprising a substitution at one or more positions corresponding to one or more of residues F64, A226, and/or E246 in Thermobifida fusca Cel9A enzyme. In certain embodiments the glycoside hydrolase is a variant of a family 9 glycoside hydrolase. In certain embodiments the glycoside hydrolase is a variant of a theme B family 9 glycoside hydrolase.
    Type: Application
    Filed: April 11, 2012
    Publication date: April 24, 2014
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Nicholas Toriello, Charles Emrich, Richard N. Cohen, Nitzan Koppel
  • Publication number: 20120142088
    Abstract: The present invention provides conjugates of DNA and cells by linking the DNA to a native functional group on the cell surface. The cells can be without cell walls or can have cell walls. The modified cells can be linked to a substrate surface and used in assay or bioreactors.
    Type: Application
    Filed: April 8, 2010
    Publication date: June 7, 2012
    Applicant: The Regents of the University of California
    Inventors: Shih-Chia Hsiao, Matthew B. Francis, Carolyn Bertozzi, Richard Mathies, Ravi Chandra, Erik Douglas, Amy Twite, Nicholas Toriello, Hiroaki Onoe